Abstract
Acquired growth hormone (GH) resistance is found in patients who have malnutrition and protein catabolism in common, such as post-surgical and critically ill patients and patients with organ failure [1]. GH resistance is the finding of high GH levels with low levels of the somatomedin insulin-like growth factor I (IGF I), which mediates the anabolic actions of GH. This may be primary, as in patients with Laron syndrome or acquired GH resistance [2]. There is now a body of evidence to suggest that the changes in the GH/IGF I axis are permissive to protein catabolism and that treatment with either GH and/or IGF I may improve the nutritional state of some patient groups [3].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ross RJM, Mieli JP, Buchanan CR (1991) Avoiding autocannibalism: consider growth hormone and insulin-like growth factor-I. BMJ 303:1147–1148
Laron Z, Blum WF, Chatelain PG et al. (1993) Classification of growth hormone insensitivity syndrome. J Pediatr 122:241
Clemmons DR (1992) Role of insulin like growth factor-I in reversing catabolism. J Clin Endocrinol Metab 75:1183–1185
Rosenfeld RG, Lamson G, Pham H et al. (1993) Insulin-like growth factor-binding proteins. Recent Prog Horm Res 46:99–163
Taylor AM, Dünger ADB, Preece MA et al. (1990) The growth hormone independent insulinlike growth factor-binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin-dependent diabetics. Clin Endocrinol (Oxf) 32:229–239
Lewitt MS, Denyer GS, Conney GJ, Baxter RC (1991) Insulin-like growth factor binding protein-1 modulates blood glucose levels. Endocrinology 129:2254–2256
Blum WF, Horn N, Kratzsch J et al. (1993) Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regul 3:100–104
Blum WF, Ranke MB (1991) Plasma IGFBP-3 levels as clinical indicators. In: Spencer EM (ed) Modern concepts of insulin-like growth factors. Elsevier, New York, pp 381–393
Ross RJM, Freeman E, Jones J, Matthews DR, Preece MA, Buchanan CR (1991) Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-1. Clin Endocrinol (Oxf) 35:47–54
Ross RJM, Mieli JP, Holly JMP, Maheshware H, Norman M, Abdulla AF, Buchanan CR (1991) Levels of GH, IGF binding proteins, insulin, blood glucose and Cortisol in intensive care patients. Clin Endocrinol (Oxf) 35:361–367
Ho KY, Veldhuis JD, Johnson ML et al. (1988) Fasting enhance growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest 81:968–975
Davies SC, Wass JAH, Ross RJM et al. (1991) The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. J Endocrinol 130:469–473
Lassarre C, Binoux M (1994) Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma. Endocrinology 134:1254–1262
Van Den Berghe G (1994) Dopamine and pituitary hormones in critical illness. Leuven University Press, Leuven
Cotterill AM, Mendel P, Holly JMP et al. (1995) The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery. Clin Endocrinol (Oxf) (Submitted)
Cuthbertson DP (1931) Observations on the disturbance of metabolism produced by injury to the limbs. Q J Med 2:233–246
Donaghy A, Ross RJM, Gimson AE, Hughes SC, Holly J, Williams R (1995) Growth hormone, insulin-like growth factor-I and insulin-like growth factor binding proteins 1 and 3 in chronic liver disease. Hepatology 21: 680–688
Mendenhall CL, Chernhausek SD, Ray MB et al. (1989) The interactions of insulin-like growth factor-I (IGF-I) with protein-calorie malnutrition in patients with alcoholic liver disease. V.A. Cooperative study on alcoholic hepatitis. Alcohol Alcohol 24:319–329
Ross RJM, Rodriguez-Arnao J, Donaghy A et al. (1994) Expression of IGFBP-1 in normal and cirrhotic human livers. J Endocrinol 141:377–382
Ross RJM, Rodriguez-Arnao J, Wraight CJ, Clark AJL (1994) Expression of IGF-I, IGFBP-1, 2, 3, and GH receptor (GHR) genes in normal liver and cirrhosis. J Endocrinol 140:111
Koea JB, Gallaher BW, Breier BH et al. (1992) Passive immunization against circulating insulin-like growth factor-I (IGF-I) increases protein catabolism in lambs: evidence for a physiological role for circulating IGF-I. J Endocrinol 135:279–284
Wilmore DW (1991) Catabolic illness, strategies for enhancing recovery. N Engl J Med 325:695–702
Mieli JP, Taylor AM, Jones J et al. (1992) Administration of recombinant insulin-like growth factor-I to patients following major gastrointestinal surgery. Clin Endocrinol (Oxf) 37:542–551
Blat C, Villaudy J, Bihoux M (1994) In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J Clin Invest 93:2296–2290
Holly JMP, Claffey P, Cwyfan Hughes SC, Frost VJ, Yateman ME (1993) Proteases acting on IGFBPs: their occurrence and physiological significance. Growth Regul 3:88–91
Ross RJM, Buchanan CR (1990) Growth hormone secretion: its regulation and the influence of nutritional factors. Nutrition Res Rev 3:143–162
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ross, R.J.M., Cotterill, A.M. (1996). The Growth Hormone/Insulin-Like Growth Factor I Axis During Surgical Stress and Critical Illness. In: Revhaug, A. (eds) Acute Catabolic State. Update in Intensive Care and Emergency Medicine, vol 21. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-48801-6_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-48801-6_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-48803-0
Online ISBN: 978-3-642-48801-6
eBook Packages: Springer Book Archive